Michigan Medicine names CEO

David Miller, MD, has been tapped as Ann Arbor, Mich.-based Michigan Medicine’s next CEO. He will step into the role July 1.

Advertisement

He will succeed Marschall Runge, MD, PhD, who has served in the role since 2015, according to a Sept. 19 news release from Ann Arbor-based University of Michigan. 

Dr. Miller currently serves as executive vice dean of clinical affairs for the University of Michigan Medical School and president of UM Health. In the role, he oversees strategic, operational, clinical and financial aspects of Michigan Medicine’s clinical enterprise, the release said.

Dr. Miller will also replace Dr. Runge as the university’s executive vice president for medical affairs, the release said. 

As dean of the medical school since 2016, Dr. Runge will retire from the leadership roles June 30 and remain a faculty member, the release said.

In his current role, Dr. Miller has guided expanding ambulatory care services at Ypsilanti (Mich.) Health Center, which is set to open next year, and has advanced programs such as hospital care at home, according to the release.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Executive Moves

  • Tammy Razmic has stepped down as CEO of StoneSprings Hospital Center in Sterling, Va., to focus on personal and family…

  • Lexington, Ky.-based UK HealthCare has named Stephen Hobbs, MD, assistant chief medical information officer for imaging informatics. In the role,…

  • Rhonda Deskins has retired as CFO of Tennova Healthcare-North Knoxville Medical Center in Powell, Tenn., according to an Aug. 6…

Advertisement

Comments are closed.